Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Software
  • Business
  • Education
  • Real Estate
Washingtoner

Blaming Patients: How Failed Treatments Fuel a $51 Billion Brain Device Industry
Washingtoner/10288490

Trending...
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Spokane: City Details Veterans Day Schedule
CCHR's New Report Exposes Dangerous Devices
CCHR's New Report Exposes Dangerous Neurological Interventions Being Pushed on Veterans, Children, and the Vulnerable

LOS ANGELES - Washingtoner -- The Citizens Commission on Human Rights International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how psychiatry is blaming patients—rather than failed treatments—to justify a surge in brain stimulation interventions. "When psychiatric drugs and therapy don't work, psychiatry rarely blames the treatment—it blames the patient, saying they are 'treatment-resistant,'" said Jan Eastgate, President of CCHR International. "'Treatment-resistant' isn't a diagnosis—it's a deflection. And it's being used to push invasive procedures like Electroconvulsive Therapy (ECT), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), and Transcranial Magnetic Stimulation (TMS)."

These brain stimulation devices were "cleared" by the Food and Drug Administration (FDA) or approved under Humanitarian Device Exemptions, bypassing the rigorous testing normally required of most medical devices. Many were greenlighted based on the device delivering ECT—a practice known for causing brain damage, memory loss, and even death[1].

Even industry insiders acknowledge concerns. "The precise physiological mechanisms of DBS are not yet fully understood," admits one clinical review.[2]  A professor of psychiatry at Brown University's Alpert Medical School, put it more starkly: "This really is a kind of mind control."[3]

The term "treatment-resistant" is a psychiatric sleight of hand, Eastgate says, now used to justify a global neurostimulation industry projected to hit $51 billion by 2030. Labeling up to 60% of psychiatric patients as "resistant" creates a false pretext for experimental interventions.[4] Meanwhile, 25% of patients develop psychotropic drug tolerance within weeks, prompting ever-riskier "solutions."[5]

Electroshock: Psychiatry's Recycled Blunder

ECT involves sending up to 460 volts through the brain to trigger seizures. Contrary to PR spin, Eastgate says, experts report modern ECT is no safer—voltage levels are higher than when broken bones were common due to convulsions.
  • FDA Loophole: Grandfathered in without clinical trials in 1976. In 2018, the FDA reclassified some ECT uses as "low risk," even for children as young as 13. Over 2,400 public comments opposed this.
  • Global Condemnation: The World Health Organization and United Nations consider ECT on children or the non-consenting a form of torture.[6]
  • Medical Harm: Neurologists equate ECT's effects to traumatic brain injury.[7] Patients are 44 times more likely to die by suicide than the general population. One in 15 ECT patients face life-threatening cardiac issues.[8]
  • Financial Cost: A $3–5.4 billion industry. Medicaid spent $9 million on ECT in 2023 in 27 states.[9] The VA and Department of Defense have administered it to veterans and children under age five.[10]

Deep Brain Stimulation: Electrodes are surgically implanted into the brain, powered by a device in the chest.
  • FDA Fast Track: Approved via Humanitarian Device Exemption for OCD in 2009 without efficacy data.
  • Harms: Stroke, hemorrhage, hallucinations, sexual dysfunction, apathy, and suicide attempts.[11]
  • Patient Testimonies: Participants in failed DBS trials report cognitive decline and emotional deterioration.[12]

Vagus Nerve Stimulation: Electrical stimulation delivered via electrodes wrapped around the vagus nerve.
  • FDA: Approved in 2005 for "treatment-resistant depression" despite lacking robust evidence.
  • Risks: Nerve damage, infection, hoarseness, breathing difficulty. The FDA has logged over 10,000 complaints involving death, injury, or device malfunction.[13]
  • Cost: Averaging $30,000+.

Transcranial Magnetic Stimulation: Magnetic pulses are aimed at the brain over six weeks.
  • Youth Approval: Cleared in 2008 for adults, and in 2024 for adolescents as young as 15.
  • Side Effects: "Brain fog," seizures, mood swings. One patient said: "This treatment destroyed my life… It gave me false hope."[14]
  • Price Tag: Up to $300 per session; full courses can reach $15,000.

Despite the sophistication of these procedures, there is still no objective medical test to diagnose any psychiatric disorder. No blood test. No brain scan. No biomarker.[15]

More on Washingtoner
  • Coming Up on CNBC: Bilha Wachira Champions Financial Protection During Long-Term Care Awareness Month
  • Tacoma: Closures Projected to Allow for Arterial Work
  • Tacoma: Applicants Sought for the Bicycle Pedestrian Technical Advisory Group
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
  • Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand

Dr. Thomas Insel, former director of the National Institute for Mental Health advised: "Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM [Diagnostic and Statistical Manual of Mental Disorders] diagnoses are based on a consensus… not any objective laboratory measure."[16]

"It's not the patient that's resistant—it's the system that's resistant to accountability," Eastgate said. "In any other field, if the intervention failed, the treatment would be reevaluated. But psychiatry doubles down, pushing more dangerous interventions instead."

CCHR urges policy makers to: End all use of ECT and brain stimulation devices for treatment of mental issues, and end ECT's role as a predicate device for newer technologies. And support humane, non-invasive, non-drug, non-brain stimulation solutions that respect patient dignity and avoid neurological and other physical harm.

CCHR, established in 1969 by the Church of Scientology and psychiatrist Dr. Thomas Szasz has a record of reforms that include banning lethal Deep Sleep Treatment, outlawing ECT use on children in several U.S. states, and securing global recognition for patient rights. Today, the United Nations and WHO echo what CCHR has long fought for: coercion has no place in mental health care.

Sources:

[1] FDA, Final Rule on Electroconvulsive Therapy Devices, Federal Register, Dec. 26, 2018; WHO-OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, p. 58, www.ohchr.org/sites/default/files/documents/publications/WHO-OHCHR-Mental-health-human-rights-and-legislation_web.pdf

[2] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025

[3] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025

[4] "Treatment resistance in psychiatry: state of the art and new directions," Mol Psychiatry, July 2021, pmc.ncbi.nlm.nih.gov/articles/PMC8960394/#fn-group1

[5] pmc.ncbi.nlm.nih.gov/articles/PMC9332474/

[6] WHO- OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, pp. 15, 58 and 59; www.cchrint.org/2023/09/18/who-guideline-condemns-coercive-psychiatric-practices/

[7] "Electroconvulsive Shock Therapy Lawsuit – What You Should Know About ECT," www.wisnerbaum.com/defective-medical-device-injuries/ect/

[8] www.cchrint.org/2024/11/08/veterans-day-cchr-calls-for-safeguards/, Peter Simons, "ECT Does Not Seem to Prevent Suicide," Mad In America, 17 Feb. 2023, www.madinamerica.com/2023/02/ect-does-not-seem-to-prevent-suicide/

More on Washingtoner
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
  • Stamp Me Launches Web App Ahead of 15th Anniversary
  • The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
  • Spokane City Council Passes Chronic Nuisance Properties Ordinance
  • City of Spokane and City Council Announce 2027 Legislative Priorities

[9] www.cchrint.org/2024/08/23/the-collapse-of-electroshock/ Based on Freedom of Information Requests to 27 states

[10] www.cchrint.org/2018/10/12/veterans-get-damaging-mental-health-deal/; Tricare Encounter Data (TED) Non-Institutional (Outpatient) for Purchased Care claims, Data Extract as of 10/21/2016, Data received from CCHR International Freedom of Information Request, 2016

[11] "Brain Stimulation Therapies," NIMH, www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml, accessed 21 Feb. 2011; Dr. Ananya Mandal, MD, "Deep Brain Stimulation Side Effects," News Medical Life Sciences, 22 July 2023, www.news-medical.net/health/Deep-Brain-Stimulation-Side-Effects.aspx

[12] Danielle Egan, "Adverse Effects: The Perils of Deep Brain Stimulation for Depression," Mad in America, 24 Sept. 2015

[13] www.hg.org/legal-articles/patients-with-complications-from-cyberonics-vns-therapy-systems-may-qualify-to-file-a-lawsuit-49467

[14] FDA MAUDE report, Neurostar TMS, 07/14/2021, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=15283600&pc=OBP

[15] www.sciencedaily.com/releases/2020/08/200817104247.htm

[16] psychrights.org/2013/130429NIMHTransformingDiagnosis.htm

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights International
Filed Under: Health, Government

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Kindering's 21st Luncheon Raises $220,000+ to Support Children with Disabilities and Their Families
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
  • Spokane: City Details Veterans Day Schedule
  • The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
  • Washington Nurse Introduces Nightingale Care Hub to Help Families Organize Care
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Flags Lowered for Spokane County Sheriff Deputies
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 308
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 269
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 166
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 137
  • Sycamore Dove Releases "Loving Every Moment" - 112
  • One in three Americans may have lost track of retirement savings from a previous job - 107
  • FloorLine Launches Live Shop Floor Tracking for Small Manufacturers - 105
  • Datavalet Named One of Quebec's Best Workplaces™ for 2026 - 101
  • Tacoma: OMWBE Active Certification Class on November 16
  • Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network

Similar on Washingtoner

  • Green Revolution CBD Spotlights Its Water-Soluble Focus Tincture With CBD, CBG and Lion's Mane
  • Tacoma: Closures Projected to Allow for Arterial Work
  • Tacoma: Applicants Sought for the Bicycle Pedestrian Technical Advisory Group
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
  • Spokane City Council Passes Chronic Nuisance Properties Ordinance
  • City of Spokane and City Council Announce 2027 Legislative Priorities
  • Security Planning Tips For Your Holiday Event From Access Patrol Services
  • Tacoma: Council Member Sandesh Sadalge Focuses Today’s District 4 Town Hall on the City’s Biennial Budget
  • City of Tacoma Awarded $2.25 Million in Federal Highway Safety Improvement Program Grant Funding for South 21st Street Corridor
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute